#in vivo gene editing

Gene Editing Just Stopped Chasing Rare Mutations

CRISPR technology is moving beyond the niche of rare genetic disorders. The focus has shifted toward common killers like cardiovascular disease and diabetes, driven by the evolution of in vivo delivery and base editing.